在病理性心肌细胞缩中,定甲基氨酸具有异形特异的分离和功能
Xiaofeng Li1, Jinliang Li1,2, Eliana C Martinez1
1Interdisciplinary Stem Cell Institute, Department of Pediatrics, Leonard M. Miller School of Medicine, University of Miami, FL (X.L., J.L., E.C.M., C.L.P., K.H., F.R., H.T., M.S.K.).
Circulation
|July 3, 2020
概括
通过与CIP4相互作用,氨酸A-β (CaNAβ) 导致病态心脏缩. 破坏这种相互作用为心脏病提供了潜在的治疗策略.
科学领域:
- 心脏病学
- 分子生物学
- 细胞信号传输
背景情况:
- 氨酸是心肌细胞增大的一个关键调节剂.
- 在病理性缩中CaNAβ异形的具体作用尚不清楚.
- 了解Ca2+信号选择性对于向疾病中的素蛋白至关重要.
研究的目的:
- 阐明心肌细胞中氨酸信号选择性的机制.
- 在病理性缩中确定CaNAβ活性的新调节剂.
- 探索针对心血管疾病的治疗策略.
主要方法:
- 酵母双混合查以确定CaNAβ相互作用蛋白.
- 在小鼠中条件基因删除和AAV介导的基因传递.
- 福斯特共振能量转移 (FRET) 生物传感器用于测量活细胞中的Ca2+和氨酸活性.
- 在体内压力过载模型 (横向大动脉收缩).
主要成果:
- CIP4被确定为CaNAβ的聚烯依赖性支架.
- 心脏肌细胞特异性CIP4缺失减弱压力过载诱导的心脏重塑.
- 干扰了CaNAβ-CIP4固,抑制了缩和改善了心脏功能.
- FRET成像显示了取决于刺激类型的细分Ca2+和氨酸信号.
结论:
- 对Ca2+和CaNAβ分离的结构模型解释了CaNAβ在缩中的作用.
- 异形特异性蛋白与蛋白相互作用调节氨酸的局部化和激活.
- 向CaNAβ-CIP4相互作用是治疗心血管疾病的一个有前途的策略.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
252
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
252
Catenins
2.9K
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.9K
Calmodulin-dependent Signaling
5.8K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.8K


